Could a simple patch replace daily spirometry for COPD patients?

NCT ID NCT07430605

Not yet recruiting Knowledge-focused Sponsor: LASARRUS Clinic and Research Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a wearable patch called WearME-Pro that tracks lung function in people with COPD during daily life. Over 10 months, 82 adults will use the patch at home and compare its readings to a standard handheld spirometer. The goal is to see if the patch is accurate, easy to use, and reliable for remote monitoring.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: WearME-Pro Patch System (wearable device)
What this could lead to: If successful, this could provide a convenient way for people with COPD to monitor their lung function at home without frequent clinic visits.
What could go wrong: This is an early-stage study with only 82 participants, and the patch readings are investigational—not yet proven to replace standard spirometry. The device may be less accurate or harder to use than expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

Contacts and locations

Locations

Johns Hopkins

Baltimore, Maryland, 21224, United States
LASARRUS Clinic and Research Center Inc.

Baltimore, Maryland, 21230, United States
TidalHealth

Salisbury, Maryland, 21801, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.